Most Read News

Revenue fell by 2.6% year-on-year to ₹4,567.4 crore against ₹4,689.3 crore in Q3 FY24, indicating a marginal slowdown in business activity.

As part of the contract, debentures shall have a tenure of 3,651 days (approx. 10 years) and shall be listed on the Wholesale Debt Market

However, the company stated that its revenue from operations registered a growth of 66.90% to ₹534.70 Crore in Q3FY25.

Top gainers in Sensex include Nestle (1.11%), TCS (0.27%), HCL Tech (0.27%), ITC (0.23%).

Following an inspection carried out from Nov 14-22 2024, the facility was cited as being ‘VAI’ (Voluntary Action Indicated).

The deal is aimed at improving operational efficiency, expanding capabilities, and fuel innovation in the maritime sector.

The company reported an 11.6% YoY de-growth in the same to ₹170 crore versus ₹192.2 crore in Q3 FY24.

In Q3 FY25, BHEL reported a 170% YoY increase in net profit, reaching ₹124 crore, while revenue grew 32% YoY to ₹7,277 crore, reflecting strong financial performance.

EBITDA was up 14.8% and stood at ₹635 crore compared to ₹553.2 crore, indicating improved operational performance.

Zydus Lifesciences announced it's Q3 FY25 and net profit grew by 30% YoY.